title: Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes.
abstract: BACKGROUND
  Growth hormone (GH) and insulin signaling pathways are known important regulators of adipose homeostasis. The cross-talk between GH and insulin signaling pathways in mature adipocytes is poorly understood.
  
  
  METHODS
  In the present study, the impact of insulin on GH-mediated signaling in differentiated 3T3-F442A adipocytes and primary mice adipocytes was examined.
  
  
  RESULTS
  Insulin alone did not induce STAT5 tyrosine phosphorylation, but enhanced GH-induced STAT5 activation. This effect was more pronounced when insulin was added 20 min prior to GH treatment. The above results were further confirmed by in vivo study, showing that insulin pretreatment potentiated GH- induced STAT5 tyrosine phosphorylation in visceral adipose tissues of C57/BL6 mice. In addition, our in vitro results showed that IGF-I had similar potentiating effect as insulin on GH-induced STAT5 activation. In vitro, insulin and IGF-I had an additive effect on GH- induced MAPK activation.
  
  
  CONCLUSIONS
  These results indicate that both insulin and IGF-I specifically potentiated GH mediated STAT5 activation in mature adipose cells. These findings suggest that insulin and GH, usually with antagonistic functions, might act synergistically to regulate some specific functions in mature adipocytes.
authors: The Institute of Cell Biology, Shandong University School of Medicine, Jinan 250012, China.
authors: Yuchao
authors: Y
authors: Zhang
authors: Yuantao
authors: Y
authors: Liu
authors: Xia
authors: X
authors: Li
authors: Weina
authors: W
authors: Gao
authors: Wenjie
authors: W
authors: Zhang
authors: Qingbo
authors: Q
authors: Guan
authors: Jing
authors: J
authors: Jiang
authors: Stuart J
authors: SJ
authors: Frank
authors: Xiangdong
authors: X
authors: Wang
mesh_terms: D016475:3T3 Cells; D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D013006:Growth Hormone; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism / Q000494:pharmacology*; D053614:Janus Kinase 2 / Q000378:metabolism; D020930:MAP Kinase Kinase Kinases / Q000378:metabolism; D051379:Mice; D010766:Phosphorylation; D050799:STAT5 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D007328:Insulin; D050799:STAT5 Transcription Factor; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D053614:Janus Kinase 2; D020930:MAP Kinase Kinase Kinases
references: Curr Opin Genet Dev. 2000 Oct;10(5):503-7
references: 10980427
references: Biochem Biophys Res Commun. 1998 Jun 29;247(3):894-900
references: 9647789
references: J Clin Invest. 1965 Jan;44:51-61
references: 14254256
references: Diabetes. 2001 Aug;50(8):1891-900
references: 11473053
references: Obesity (Silver Spring). 2006 Aug;14(8):1303-11
references: 16988072
references: Endocr Rev. 1985 Spring;6(2):128-50
references: 2861084
references: EMBO Rep. 2002 Jan;3(1):95-100
references: 11751579
references: J Biol Chem. 2004 May 14;279(20):20898-905
references: 15010456
references: Diabetes. 2005 Jul;54(7):1968-75
references: 15983196
references: Biochem J. 1992 Jun 15;284 ( Pt 3):649-52
references: 1377909
references: J Clin Invest. 2000 Jul;106(2):165-9
references: 10903329
references: Mol Endocrinol. 2009 Apr;23(4):486-96
references: 19164446
references: Endocrinology. 1988 May;122(5):2084-9
references: 3282874
references: Diabetologia. 2004 Feb;47(2):170-84
references: 14722654
references: J Biol Chem. 2002 Aug 9;277(32):28384-93
references: 12161450
references: Nature. 2001 Dec 13;414(6865):799-806
references: 11742412
references: Biochem Biophys Res Commun. 2003 Mar 7;302(2):359-62
references: 12604355
references: J Biol Chem. 1999 Aug 6;274(32):22484-92
references: 10428824
references: Mol Cell Endocrinol. 2000 Apr 25;162(1-2):121-9
references: 10854705
references: J Biol Chem. 1996 Mar 8;271(10):5929-40
references: 8621467
references: Biochem Biophys Res Commun. 1999 Sep 16;263(1):201-5
references: 10486277
references: J Mol Endocrinol. 2003 Apr;30(2):139-50
references: 12683938
references: Trends Endocrinol Metab. 2011 Aug;22(8):325-32
references: 21561789
references: Mol Endocrinol. 2004 Jun;18(6):1471-85
references: 15044591
references: Annu Rev Physiol. 1985;47:483-99
references: 3888078
references: Mol Cell Biol. 1999 Apr;19(4):2913-20
references: 10082558